Clorox (NYSE:CLX) reported quarterly earnings of $1.31 per share which beat the analyst consensus estimate of $0.97 by 35.05 percent. This is a 19.14 percent decrease over earnings of $1.62 per share from the same period last year. The company reported quarterly sales of $1.80 billion which met the analyst consensus estimate. This is a 1.07 percent increase over sales of $1.78 billion the same period last year.
Related Posts
G Medical Innovations Holdings Announces Receipt Of Nasdaq Minimum Bid Price Notification
G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals,
RBC Capital Maintains Outperform on Shift4 Payments, Raises Price Target to $110
RBC Capital maintains Shift4 Payments (NYSE:FOUR) with a Outperform and raises the price target from $95 to $110.
‘Tesla Supplier Core Lithium Says it’s Ready to Start Delivering Lithium by End of Year’ – Tesmanian
https://www.tesmanian.com/blogs/tesmanian-blog/tesla-supplier-core-lithium-says-its-ready-to-start-delivering-lithium-by-the-end-of-the-year